Eun Seok Kang
Overview
Explore the profile of Eun Seok Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
4341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim Y, Yu M, Nam C, Kang E
Diabetes Metab J
. 2025 Mar;
49(2):252-263.
PMID: 40073907
Backgruound: Despite diabetes mellitus (DM) and pancreatitis being known risk factors for pancreatic cancer, patients with these conditions are not included in pancreatic cancer screening due to the low incidence...
2.
Bhak Y, Lee Y, Kim J, Lee K, Lee D, Jang E, et al.
JMIR Med Inform
. 2025 Feb;
13:e55825.
PMID: 39924305
Background: Chronic kidney disease (CKD) is a prevalent condition with significant global health implications. Early detection and management are critical to prevent disease progression and complications. Deep learning (DL) models...
3.
Hong S, Kim W, Kang E, Jeong I, Kim C, Lee K, et al.
Diabetes Obes Metab
. 2024 Dec;
27(3):1242-1250.
PMID: 39703109
Aims: This study evaluated the efficacy and safety of a combination of phentermine and delayed-release topiramate (PHEN/TPM CR) versus placebo as an adjunct to standard lifestyle recommendations in Korean adults....
4.
Kim Y, Kim D, Kim J, Yun M, Kang E
ESC Heart Fail
. 2024 Sep;
12(1):467-476.
PMID: 39344859
Background: Low muscle mass is associated with high insulin resistance and an increased risk of cardiovascular disease. This study aims to determine whether low muscle mass affects the alterations in...
5.
Kim H, Biessels G, Yu M, Hong N, Lee Y, Lee B, et al.
Neurology
. 2024 Sep;
103(8):e209805.
PMID: 39292986
Background And Objectives: Despite the mechanistic potential of sodium-glucose cotransporter 2 inhibitor (SGLT2i) to improve neurologic outcomes, the efficacy of SGLT2i in neurodegenerative disorders among patients with type 2 diabetes...
6.
Kim J, Jin S, Sim K, Kim B, Cho J, Moon J, et al.
Diabetologia
. 2024 Apr;
67(7):1223-1234.
PMID: 38639876
Aims/hypothesis: The aim of this study was to compare the effectiveness of stand-alone intermittently scanned continuous glucose monitoring (isCGM) with or without a structured education programme and blood glucose monitoring...
7.
Kim J, Jin S, Kang E, Kwak S, Yang Y, Yoo J, et al.
Diabetologia
. 2024 Apr;
67(7):1235-1244.
PMID: 38634887
Aims/hypothesis: This study compares the efficacy and safety of a tubeless, on-body automated insulin delivery (AID) system with that of a tubeless, on-body sensor-augmented pump (SAP). Methods: This multicentre, parallel-group,...
8.
Han E, Lee B, Kang E, Cha B, Ahn S, Lee Y, et al.
Metabolism
. 2024 Feb;
154:155819.
PMID: 38412589
No abstract available.
9.
Lee S, Bae J, Kim S, Lee M, Lee Y, Kang E, et al.
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1306134.
PMID: 38260169
Aim: Hepatic ketogenesis is a key metabolic pathway that regulates energy homeostasis. Some related controversies exist regarding the pathogenesis of metabolic-associated fatty liver disease (MAFLD). We aimed to investigate whether...
10.
Han E, Lee B, Kang E, Cha B, Ahn S, Lee Y, et al.
Metabolism
. 2024 Jan;
152:155789.
PMID: 38224909
Background: A new fatty liver disease nomenclature, steatotic liver disease (SLD) has been proposed; however, there are no data on clinical outcomes. We investigated the impact of SLD with metabolic...